Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662453 · ClinicalTrials.gov registry record
Risk Factors for Sudden Unexplained Death in Epilepsy
A clinical trial of SUDEP, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT01662453: Recruiting study of SUDEP, sponsored by NYU Langone Health.
NCT01662453 is a study of SUDEP that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 800 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01662453, a study of SUDEP, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief telephone interview about their loved one's epilepsy and seizure history and the circumstances of his or her death. If the death has occurred within the past 24 hours, and the family is willing to consider donating tissue to the study, the subject will be transferred to the Autism Tissue Program, and the remainder of the phone interview will be conducted at a later time. In addition to the phone interview, the family will be asked to provide access to the deceased's medical records. Any costs involved in obtaining medical records will be covered by the study, and all medical information will remain completely confidential.
Primary Outcome
Number of incidents of sudden unexplained deaths in epilepsy patients (SUDEP) and types of risk factors for SUDEP.
Conditions Studied
Study Locations (1)
New York
- NYU Comprehensive Epilepsy Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2011-06 |
| Est. Completion | 2026-09 |
What NCT01662453 shows while recruiting
NCT01662453 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with SUDEP appearing as the primary indexed condition, and to 0 interventions.
NCT01662453 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01662453 about?
NCT01662453 is a clinical study titled "Risk Factors for Sudden Unexplained Death in Epilepsy". The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief te...
What is the current status of trial NCT01662453?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2011-06. Estimated completion is 2026-09.
What conditions does trial NCT01662453 study?
This clinical trial studies the following conditions: SUDEP.
Who is sponsoring clinical trial NCT01662453?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01662453 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SUDEP
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia